Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Preliminary study reveals promising results of new treatment for progressive MS

Preliminary study reveals promising results of new treatment for progressive MS

Study finds link between circadian variations in body temperature and arousal in brain-injured patients

Study finds link between circadian variations in body temperature and arousal in brain-injured patients

Study shows evidence that old drug may provide relief for advanced Parkinson's disease patients

Study shows evidence that old drug may provide relief for advanced Parkinson's disease patients

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Cannabidiol shows promise to reduce seizures for people with difficult-to-treat epilepsy

Microscopic probes simplify process of measuring electrical signals in small animals

Microscopic probes simplify process of measuring electrical signals in small animals

Cell cultures in petri dishes open new doors to brain research

Cell cultures in petri dishes open new doors to brain research

Opportunities and risks of direct-to-consumer genetic health risk tests

Opportunities and risks of direct-to-consumer genetic health risk tests

Obesity and being underweight linked to increased risk for migraine

Obesity and being underweight linked to increased risk for migraine

'Human knockouts': Genetics in families reveals basic biology and possible therapeutics for disorders

'Human knockouts': Genetics in families reveals basic biology and possible therapeutics for disorders

Study shows um-PEA as safe and efficacious adjuvant treatment for advanced PD patients

Study shows um-PEA as safe and efficacious adjuvant treatment for advanced PD patients

Researchers design first light-activated drug for treatment of pain

Researchers design first light-activated drug for treatment of pain

New study finds link between neural tube defects in infants and neurodegenerative diseases

New study finds link between neural tube defects in infants and neurodegenerative diseases

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

Study finds thalamic DBS to be safe, effective treatment for young adults with Tourette syndrome

Biomedical engineers develop new method for delivering drugs to specific neurons

Biomedical engineers develop new method for delivering drugs to specific neurons

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

FDA authorizes marketing of first direct-to-consumer GHR tests for certain diseases

Regular exercise, not body fat, may help predict person's recovery from stroke

Regular exercise, not body fat, may help predict person's recovery from stroke

Digitising health records could have positive impact on diagnosis and treatment of illnesses

Digitising health records could have positive impact on diagnosis and treatment of illnesses

Common neurological diseases pose serious annual financial burden for the U.S.

Common neurological diseases pose serious annual financial burden for the U.S.

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds